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Although dendritic cells (DCs) play an important role in sensitization to inhaled allergens, 
their function in ongoing T helper (Th)2 cell–mediated eosinophilic airway inflammation 
underlying bronchial asthma is currently unknown. Here, we show in an ovalbumin (OVA)-
driven murine asthma model that airway DCs acquire a mature phenotype and interact with 
CD4
 
 
 
 T cells within sites of peribronchial and perivascular inflammation. To study whether 
DCs contributed to inflammation, we depleted DCs from the airways of CD11c-diphtheria 
toxin (DT) receptor transgenic mice during the OVA aerosol challenge. Airway administration 
of DT depleted CD11c
 
 
 
 DCs and alveolar macrophages and abolished the characteristic 
features of asthma, including eosinophilic inflammation, goblet cell hyperplasia, and bronchial 
hyperreactivity. In the absence of CD11c
 
 
 
 cells, endogenous or adoptively transferred CD4
 
 
 
 
Th2 cells did not produce interleukin (IL)-4, IL-5, and IL-13 in response to OVA aerosol. In 
CD11c-depleted mice, eosinophilic inflammation and Th2 cytokine secretion were restored 
by adoptive transfer of CD11c
 
 
 
 DCs, but not alveolar macrophages. These findings identify 
lung DCs as key proinflammatory cells that are necessary and sufficient for Th2 cell 
stimulation during ongoing airway inflammation.
 
Allergic asthma is a chronic inflammatory dis-
ease of the airways associated with a predomi-
nant Th2 response to inhaled allergens leading
to airway infiltration by eosinophils and mast
cells, goblet cell hyperplasia, and bronchial hy-
perreactivity (1). Despite significant progress in
our understanding of disease pathophysiology,
prevalence continues to rise, particularly in
Western societies. As effector Th2 lymphocytes
are intimately involved in controlling the var-
ious aspects of the disease, elucidating the
mechanisms by which these cells are activated
in response to allergen challenge should lead to
novel ways of treatment (2).
DCs are important antigen-presenting cells
in the immune system, mainly recognized for
their extraordinary capacity to induce primary
immune responses (3, 4). Airway DCs form a
network in the bronchial epithelium, capture
inhaled antigen, and migrate to the mediastinal
LNs (MLNs) where antigen is presented to re-
circulating naive CD4
 
 
 
 and CD8
 
 
 
 T cells (5–9).
Not surprisingly, antigen presentation by air-
way DCs is at the basis of the Th2 sensitiza-
tion process that occurs in patients with allergy
and animals exposed to OVA antigen (2, 10–
14). Despite these known functions of DCs
on primary immune responses and allergic
sensitization, it is less clear if airway DCs are
also necessary for the presentation of allergen
to resting memory Th2 and/or effector Th2
cells during a secondary immune response. In
favor of DCs, it is known that the number
and maturation state of lung DCs is elevated
during secondary immune challenge with al-
lergens and during chronic airway inflamma-
tion (15–17). This suggests that DCs are
functionally involved in presenting allergens
to T cells and, thus, control airway inflamma-
tion (10, 12, 18, 19). Arguing against a role
for DCs is the notion that previously primed
T cells have less need for costimulation in
comparison with naive T cells, which led to
the hypothesis that any peripheral APC ex-
pressing MHC II could stimulate effector Th2
cells (20–22).
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To examine more clearly the need for DCs in the induc-
tion and maintenance of effector Th2 responses to allergen
challenge, we decided to deplete these cells during OVA aero-
sol exposure of OVA-sensitized mice. Conditional depletion
of DCs has recently become possible because we generated
transgenic (Tg) mice in which the CD11c promotor element
drives the expression of the monkey diphtheria toxin (DT) re-
ceptor (23). Murine cells are normally insensitive to DT as
they lack the DT receptor. In CD11c-DTR mice, we were
able to show that systemic administration of DT leads to a
rapid decline in CD11c
 
 
 
 DCs in the spleen, leading to a defect
in CD8
 
 
 
 T cell priming (23). Here, we adopted this strategy
and administered DT locally to the airways, allowing the in-
ducible, short-term ablation of lung CD11c
 
 
 
 cells. Our data
show that in the absence of CD11c
 
 
 
 DCs, OVA allergen chal-
lenge in sensitized mice failed to elicit effector cytokine release
by endogenous primed Th2 cells or adoptively transferred
primed CD4
 
 
 
 Th2 cells. Importantly, depletion of CD11c
 
 
 
cells abolished the cardinal features of asthma, but these fea-
tures were restored by adoptive transfer of CD11c
 
 
 
 DCs, but
not alveolar macrophages. These studies indicate that lung
DCs are necessary and sufficient antigen-presenting cells in-
volved in the development and maintenance of asthmatic air-
way inflammation.
 
RESULTS
DCs acquire a mature phenotype and colocalize with T cells 
within peribronchial eosinophilic inflammation
 
We have reported previously in a mouse model of asthma that
the number of CD11b
 
 
 
CD11c
 
 
 
 DCs increases up to 100-
fold in the bronchoalveolar lavage fluid (BALF) after OVA
challenge in OVA-sensitized mice, but have not studied the
functional implications of this increase (17). First, we per-
formed a detailed phenotypical analysis of DCs in the BALF,
lung tissues, and MLNs (Fig. 1 A) of mice with or without
eosinophilic airway inflammation (Fig. 1 A). In mice with air-
way inflammation, there was a consistent increase in expres-
sion of the costimulatory molecules CD80, ICAM-1, CD40,
PDL-1, and PDL-2 on endogenous CD11c
 
 
 
 MHCII
 
 
 
 DCs
in the BALF and lung tissue compartment compared with
control mice. In the MLNs, the costimulatory molecules
CD80, CD86, ICAM-1, and CD40 were consistently higher
on DCs of allergic mice. To determine whether DCs inter-
acted locally with CD4
 
 
 
 T cells at the site of inflammation,
we stained cryosections of lungs of OVA-sensitized and chal-
lenged mice for the presence of CD11c
 
 
 
 DCs and CD4
 
 
 
 T
cells. Clusters of T cells and CD11c
 
 
 
 DCs were seen in eosin-
ophil-rich peribronchial and perivascular infiltrates (Fig. 1 B
and Fig. 2 B) and in the surrounding parenchyma. Multiple
large CD11c
 
 
 
 cells were also present in the alveolar compart-
ment, frequently surrounded by small CD4
 
 
 
 cells (Fig. 1 C).
 
Intratracheal (i.t.) injection of DT depletes CD11c
 
 
 
 cells in 
CD11c-DTR Tg mice
 
The acquisition of a mature phenotype within the lung and the
close interaction between DCs and CD4
 
 
 
 T cells within areas
of inflammation suggested that DCs were necessary for stimulat-
ing antigen-specific primed T cells. To investigate the functional
role of this interaction, we used CD11c-DTR Tg BALB/c
mice in which administration of DT allows a conditional abla-
tion of CD11c
 
 
 
 cells (23). In the mouse, CD11c is highly ex-
pressed on myeloid DCs, as well as on alveolar macrophages and
some activated CD8
 
 
 
 T cells. FACS analysis revealed that i.t.
injection of 50 ng DT in naive CD11c-DTR Tg mice depleted
Figure 1. Phenotype of DCs in bronchoalveolar compartment, lung, 
and lung draining LNs in steady-state and during inflammation. 
(A) BALB/c mice were OVA sensitized and challenged (OVA/OVA), or as a 
control sham sensitized/challenged (PBS/PBS), to induce an eosinophilic 
airway inflammation. DCs were analyzed for the expression of molecules 
needed for T cell interaction. DCs were recognized as CD11c /MHCII  (top). 
Black lines indicate marker expression and gray lines indicate the isotype 
control staining. (B) 1 d after the last aerosol, peribronchial infiltrates were 
analyzed for the presence of CD4  T cells (blue) and CD11c  DCs (red) in 
frozen lung sections. Bar, 100  m. (C) At a larger magnification, it is shown 
that DCs and T cells are interacting in the peribronchial infiltrates as well 
as in the lung parenchyma. Bar, 10  m. 
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local CD11c
 
 
 
 MHCII
 
 
 
 DCs in BALF, lung tissue, and MLNs
(Fig. 2 A, left). However, in addition, the number of systemic
DCs were affected, although not in the degree seen in the air-
ways (Fig. 2 A, right). DT also depleted CD11c
 
 
 
, MHCII
 
int
 
highly autofluorescent alveolar macrophages in the BALF and
lung tissue of naive mice (Fig. 2 A). Next, we determined in
OVA-sensitized and -challenged mice that i.t. injection of 50 ng
DT before challenge depleted CD11c
 
 
 
 DCs in CD11c-DTR
Tg mice, but not in nonTg (nTg) littermates. Control PBS-
injected Tg mice had massive amounts of CD11c
 
 
 
 cells within
sites of inflammation (Fig. 2 B).
 
Conditional depletion of CD11c
 
 
 
 cells in sensitized animals 
abolishes the cardinal features of asthma
 
DT-induced DC depletion allowed us to study the response
to OVA challenge in OVA-sensitized mice in the presence
or absence of DCs. CD11c-DTR Tg and wild-type nTg lit-
termates were sensitized to OVA on day 0 by giving an i.t.
injection of OVA-pulsed bone marrow–derived DCs. At
day 10, both groups of mice were injected i.t with 50 ng DT
and were subsequently challenged with three daily OVA
aerosols during days 11–13. In nTg mice, this protocol induces
eosinophilic airway inflammation only when OVA-pulsed
DCs are used for immunization (reference 8 and unpublished
data). Analysis of BALF cells of mice that were depleted of
DCs (CD11c-DTR Tg mice treated with DT will be re-
ferred to as Tg DC
 
 
 
) before challenge with OVA aerosols
revealed a significantly lower number of total BALF cells and
eosinophils compared with mice that were not DC depleted
(nTg littermates treated with DT are referred to as nTg DC
 
 
 
and Tg animals treated with PBS are referred to as Tg
DC
 
 
 
; Fig. 3, A and B). In concordance, histological analysis
Figure 2. DT treatment depletes CD11c  cells in CD11c-DTR Tg mice. 
Naive CD11c-DTR Tg and nTg mice were i.t. injected with 50 ng DT 
(Tg DT and nTG DT) or only PBS (Tg PBS). (A, left) 48 h after instillation, 
BALF cells, lungs, and lung draining LNs were analyzed for the presence of 
CD11c MHCII  DCs by FACS. (right) Systemic effects of DT on peripheral 
axillary LNs and splenic DCs. (B) OVA-sensitized Tg and nTg mice were 
treated with DT or PBS and received three OVA aerosols. Lung sections 
stained for CD4  (blue) and CD11c  (red) cells showed that i.t. administra-
tion of 50 ng DT in Tg mice before challenge, inhibited the induction of 
peribronchial infiltrates containing CD4  and CD11c  cells (left), whereas 
in nTg mice (right) DT did not affect CD11c  DCs. As a control, Tg mice 
were treated with PBS (middle), showing a similar peribronchial infiltrate 
as in WT mice. The results shown represent two independent experiments. 
Bars, 100  m. 
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of Tg DC
 
 
 
 mice did not show peribronchial and perivascu-
lar inflammatory infiltrates as seen in nTg DC
 
 
 
 mice or Tg
DC
 
 
 
 mice (unpublished data). To measure bronchial hyper-
responsiveness, Tg DC
 
 
 
 and nTg DC
 
 
 
 mice were exposed
to increasing doses of metacholine. After OVA challenge,
nTg DC
 
 
 
 mice had an increase in PenH over baseline after
exposure to 6.25, 12.5, and 25 mg/ml metacholine com-
pared with nTg DC
 
 
 
 mice challenged with PBS aerosol
challenge, illustrating the induction of airway hyperrespon-
siveness (AHR) by OVA challenge in OVA-sensitized mice.
In contrast, after OVA challenge, Tg DC
 
 
 
 mice had an
AHR curve that followed the curve seen in Tg DC
 
 
 
 and
nTg DC
 
 
 
 mice that were OVA sensitized but were chal-
lenged with PBS (Fig. 3 C).
Next, we determined whether the absence of these car-
dinal features of asthma in CD11c
 
 
 
 cell–depleted mice was
associated with an inability to generate effector function in
primed Th2 cells. In vitro restimulation of lung draining LN
cells with OVA showed that DC depletion before allergen
challenge greatly diminished IL-4, IL-5, and IL-13 produc-
tion, whereas IFN
 
 
 
 production was unaffected (Fig. 3 D).
Supporting an essential role for DCs in eliciting effector cy-
tokine release from primed Th2 cells, we performed adop-
tive transfer experiments in which previously primed in
vitro–generated OVA-specific Th2 cells from D011.10 mice
were injected intravenously into naive Tg DC
 
 
 
 and Tg
DC
 
 
 
 and nTg DC
 
 
 
 mice. As described previously (24),
OVA aerosol challenge leads to Th2 cytokine production by
these adoptively transferred Th2 cells in mice with DCs
(Tg DC
 
 
 
 and nTg DC
 
 
 
). However cytokine production
was impaired in recipient mice (Tg DC
 
 
 
) that were depleted
of DCs (Fig. 3 E).
 
DC reconstitution restores eosinophilic airway inflammation 
in DC-depleted mice
 
Because CD11c is also expressed by alveolar macrophages
and weakly by activated CD8
 
 
 
 T cells and eosinophils, we
performed adoptive transfer reconstitution experiments after
depletion with DT to test our hypothesis that DCs are indeed
the cells required for the induction of the secondary immune
response. Tg DC
 
 
 
 mice received at the time of OVA aerosol
challenge i.t. 2 
 
 
 
 10
 
6
 
 unpulsed DCs, i.t. 2 
 
 
 
 10
 
5
 
 alveolar
Figure 3. DC requirement for induction of secondary immune 
responses. Mice were OVA sensitized at day 0, received a DT i.t. injection 
at day 10, and received a daily 30-min aerosol at days 11–13. At day 14, 
mice were killed. (A) BALF cells were analyzed for total BALF numbers and 
(B) the number of eosinophils 1 d after the last aerosol. (C) AHR was 
measured in CD11c-DTR Tg mice and nTg littermates that were sensitized 
with OVA (alum) and challenged with three OVA aerosols or as a control 
with PBS aerosols. 24 h before the first OVA aerosol, all mice were
treated with DT. Tg DC /OVA, OVA-challenged DC-depleted CD11c-DTR 
Tg; nTg DC /OVA, OVA-challenged nTg mice; Tg DC /PBS, PBS-challenged 
DC-depleted CD11c-DTR Tg; nTg DC /PBS, PBS-challenged nTg. (D) Th2 
cytokine production by lung draining LNs in Tg DC , Tg DC , and nTg 
DC  mice. (E) A cohort of in vitro–obtained memory Th2 were adoptively 
transferred (i.v.) into Tg DC  and nTg DC , simultaneously with an i.t. in-
jection of DT or as a control PBS (Tg DC ). 24 h after the adoptive trans-
fer, mice were challenged with OVA aerosols for 4 d. Lung draining LNs 
were restimulated ex vivo with OVA and IL-4, IL-5, IL-13, and IFN  levels 
were determined in supernatant by ELISA (*, P   0.05 vs. nTg DC ). The 
results shown represent one out of five independent experiments and are 
expressed as means   SEM. 
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macrophages, i.t. 10
 
6
 
 eosinophils, or i.v. 7.5 
 
 
 
 10
 
6
 
 CD8
 
 
 
 T
cells. Reconstitution with unpulsed DCs in Tg DC
 
 
 
 mice
increased total BALF cells (Fig. 4 A) and was able to restore
the absolute number of eosinophils in BALF (Fig. 4 B) as
well as Th2 cytokine production in lung draining LNs
(Fig. 4 C) and inflammatory peribronchiolar and perivascular
infiltrates (Fig. 4 E) to a similar level seen in Tg DC
 
 
 
 (Fig. 4
F) and nTg DC
 
 
 
 (Fig. 4 G). Th2 cytokine production was
the highest in the group receiving adoptive transfer of un-
pulsed DCs. In contrast, adoptive transfers with macro-
phages, CD8
 
 
 
, or eosinophils were unable to restore the re-
sponse to OVA challenge in Tg DC
 
 
 
, as shown by the lack
of recruitment of eosinophils to the BALF compartment
(Fig. 4 H).
 
DC depletion during ongoing Th2 inflammation diminishes 
cardinal features of asthma
 
Next, we determined the role of lung DCs during an ongo-
ing inflammation in which effector Th2 cells are already
present in the lung and eosinophilia is established. CD11c-
DTR Tg or nTg mice were sensitized to OVA and chal-
lenged at days 10–12 with daily OVA aerosol (8). On day
13, when both groups had an eosinophilic airway inflamma-
tion, DT was given intratracheally to both groups to gener-
ate nTg DC
 
 
 
 and Tg DC
 
 
 
 mice. Mice were subsequently
challenged for another three times at days 14–16 by daily
OVA aerosol. One additional group of CD11c-DTR Tg
mice received the same treatment but was challenged with
PBS aerosols at days 14–16 after DC depletion (Tg DC
 
 
 
/
PBS) to determine the resolution of airway inflammation in
the absence of allergen challenge. Analysis of Tg DC /OVA
mice revealed a lower number of total BALF cells and eosin-
ophils compared with nTg DC /OVA mice (Fig. 5, A and
B; 0.18   106 vs. 106 eosinophils). In Tg DC /OVA mice,
BALF cellularity and eosinophilia was similar to that seen in
Tg DC /PBS mice, suggesting that OVA was not presented
by other CD11c  APCs. In support, IL-4, IL-5, and IL-13
cytokine production by lung draining LNs of Tg DC /
OVA mice was decreased compared with nTg DC /OVA
littermates. Also, Tg DC /PBS-challenged mice produced
lower, although not significantly, levels of IL-4, IL-5, and
IL-13 (Fig. 5 C). Histological analysis revealed significantly
(P   0.032) less inflammatory peribronchial and perivascular
infiltrates and goblet cell hyperplasia in Tg DC /OVA mice
(Fig. 5 D) and DC /PBS (Fig. 5 E) compared with nTg
DC /OVA mice (Fig. 5 F). Tg DC /OVA mice had a
mean inflammatory area ratio of 0.49 compared with 0.77 in
nTg DC  mice (P   0.001). In Tg DC  mice in which PBS
aerosol was given during the last 3 d, inflammation was least
prominent (area ratio of 0.13; P   0.0001 compared with
Tg DC /OVA).
Adoptive transfer of DCs is sufficient to induce all asthmatic 
features in sensitized mice
Next, we investigated whether DCs have an intrinsic capac-
ity to induce a secondary immune response in sensitized ani-
mals, without any form of adjuvant or aerosol exposure.
Mice were sensitized by i.t. injection of 106 OVA-pulsed
DCs (OVA-DCs). On days 10 and 12, mice were challenged
i.t. with OVA-DCs (DC/DC group). As a positive control
Figure 4. DC reconstitution restored eosinophilic airway inflam-
mation. CD11c-DTR Tg and nTg mice were OVA sensitized at day 0,
received i.t. DT (Tg DC , Tg DC    DC i.t. and nTg DC ) or PBS (Tg DC ) at 
day 10 and were challenged with OVA aerosols at days 11–13. Mice were 
reconstituted with unpulsed 2   106 DCs i.t. immediately after OVA chal-
lenge. BALF was analyzed for (A) total BALF numbers and (B) the number 
of eosinophils at day 14. (C) Th2 cytokine production by MLN after ex vivo 
restimulation with OVA was measured in supernatant by ELISA (*, P   0.05 
vs. Tg DC ). (D–G) Histological sections of Tg DC , Tg DC    DC i.t., Tg DC , 
and nTg DC  mice stained with PAS reagent. Bars, 100  m. (H) Number of 
eosinophils in BALF after reconstitution with macrophages, CD8  cells or 
eosinophils (*, P   0.05 vs. C). The results shown represent one out of two 
independent experiments and are expressed as means   SEM.DENDRITIC CELLS IN ASTHMA | van Rijt et al. 986
for the efficiency of sensitization, some sensitized mice re-
ceived four daily OVA (DC/OVA group) or PBS (DC/PBS
group) aerosols for 30 min, starting at day 10. On day 14, to-
tal recovery of BALF cells and BALF eosinophilia in both
DC/DC mice and DC/OVA mice were identical and  20
times higher than in DC/PBS mice (Fig. 6, A and B). These
data were supported by similar levels of Th2 cytokines seen
in DC/DC mice compared with DC/OVA mice (Fig. 6 C).
Histological analysis revealed intense peribronchial and
perivascular eosinophilic infiltrates and goblet cell hyperpla-
sia,  of similar intensity in DC/DC and DC/OVA mice
(Fig. 6, D and E; P   0.2). As expected, DC/PBS mice did
not develop eosinophilic airway inflammation (Fig. 6 F; P  
0.008 vs. DC/OVA and P   0.016 vs. DC/DC). Quantita-
tive histological analysis (area ratio) resulted in similar find-
ings as obtained with ranking by investigators: DC/PBS,
0.05 versus DC/OVA, 0.65 (P   0.0001) or DC/DC, 0.59
(P   0.0001). DC/DC and DC/OVA mice both had a sig-
nificant increase in PenH after metacholine inhalation com-
pared with DC/PBS mice, indicative of induction of bron-
chial hyperreactivity (Fig. 6 G; P   0.05). These findings did
not occur in NOD/SCID mice, suggesting that DCs re-
quired interaction with T cells to generate inflammation and
were not proinflammatory per se (unpublished data).
DISCUSSION
Although it is generally accepted that effector Th2 cells and
their secreted products are important in controlling the car-
dinal features of asthma, little is known about their activation
in response to allergen inhalation (2). DCs are believed to be
the most important APCs in the lung in steady-state (2, 3,
12) and are mainly known for their potential to induce the
activation of naive T cells in the draining MLNs leading to
antimicrobial, antitumoral, and allergic T cell responses (9,
25, 26). However, from the perspective of T cell–mediated
diseases such as atopic asthma, an important question is
whether lung DCs are also responsible for the reactivation of
allergen-specific primed T cells at times of allergen challenge
and, therefore, would constitute a target for therapeutic in-
tervention. Evidence is accumulating that DCs are indeed
responsible for the reactivation of these primed Th2 cells
upon allergen challenge (for review see reference 12). Rele-
vant allergen challenge to the airways of allergic asthmatics
leads to the recruitment of circulating DCs to the airways
and stable asthmatics have higher numbers of airway lining
DCs (15, 16). Similarly, OVA allergen challenge in OVA-
sensitized rodents increased the number of myeloid DCs in
the airway mucosa, interstitial, and bronchoalveolar com-
partment, at a time point that CD4  T cells were also accu-
mulating in the lungs (10, 17, 27).
These data suggest in an indirect way that airway DCs
might be involved in the functional restimulation of previ-
ously primed Th2 cells. In this work, we have directly ad-
dressed this issue by studying the role of CD11c  lung DCs
in a well-established mouse model for asthma induced by in-
halation of OVA in OVA-sensitized mice. First, we con-
firmed that, upon allergen challenge to the lung, CD11c 
cells acquired a mature phenotype expressing essential co-
stimulatory molecules (CD80, CD40, ICAM-1, PDL-1, and
PDL-2) when resident within the inflamed lung. CD11c 
DCs accumulated within sites of eosinophilic airway inflam-
mation and clustered with CD4  T cells in the airway sub-
mucosa and the perivascular space at areas of intense eosino-
philic inflammation, forming multiple contacts with CD4 
Figure 5. DC requirement for maintaining eosinophilic airway 
inflammation. CD11c-DTR Tg (Tg DC /OVA) and nTg mice (nTg DC /OVA) 
were OVA sensitized at day 0, received a daily 30-min aerosol at days 11–13. 
At day 14, mice received DT, and at days 15–17 mice were challenged daily 
with a 30-min OVA. One group of CD11c-DTR Tg mice (Tg DC /PBS) 
received the same treatment but was challenged with PBS aerosol after 
DC depletion. BALF was analyzed for (A) total BALF numbers and (B) the 
number of eosinophils. (C) Th2 cytokine production by MLN after ex vivo 
restimulation with OVA was measured in supernatant by ELISA. (D–F) His-
tological sections of Tg DC /OVA, Tg DC /PBS, and nTg DC /OVA mice 
stained with PAS reagent (*, P   0.05 vs. nTg DC  /OVA). The results 
shown represent one out of three independent experiments and are
expressed as means   SEM. Bars, 100  m.JEM VOL. 201, March 21, 2005 987
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T cells (28). The consequences of this interaction with T
cells have been studied elegantly by Huh et al. in a rat model
of asthma. After a single OVA aerosol challenge in OVA-
sensitized rats, airway DCs accumulated in the airway mu-
cosa and submucosa and formed contacts with primed T
cells, in turn inducing the up-regulation of costimulatory
molecules on otherwise immature airway DCs (10). These
authors hypothesized that contact with primed T cells turns
immature mucosal DCs from an antigen uptake to an anti-
gen-presenting mode, leading to local antigen presentation
to mucosal T cells (10). Strikingly, we also observed an in-
crease in the B7 family members PDL-1 and PDL-2, ligands
of the inhibitory PD-1 receptor. Although signaling through
PD-1 is generally seen as an inhibitory signal, recent data
suggest that PDL-1 might also provide a costimulatory signal
to T cells (28). In support, blocking PDL-1/PDL-2 using
PD1-Fc has the potential to suppress eosinophilic airway in-
flammation (unpublished data).
As intense local interactions between primed CD4  T
cells and locally matured DCs are a feature of eosinophilic
airway inflammation across species, next we studied whether
effector CD4  T cells functionally depend on DCs to exert
their effector functions and, in this way, orchestrate airway
inflammation. We addressed this question by using a novel
system of conditional depletion of CD11c  cells expressing a
DT receptor transgene under the control of the CD11c pro-
moter (23). Systemic administration of DT to these mice
leads to the rapid reduction in splenic and LN CD11c  DCs,
and concomitantly to an absence of the primary cytotoxic
T cell responses to Listeria infection or experimental admin-
istration of protein antigens (19). Here, we adopted this
strategy and administered the DT locally via i.t. injection,
leading to a loss of CD11c  cells in the BALF and lung tis-
sues (DCs and macrophages) and draining MLNs (DCs).
We cannot explain at present by what mechanism the
CD11c  DCs were depleted from the MLNs, but we specu-
late that they were reduced because of the loss of import of
freshly migrating DCs from the mucosa, as these DCs have a
very short half-life in the mucosa and continuously migrate
to the nodes even in noninflammatory conditions (7, 29, 30).
Alternatively, DT might have reached the MLNs directly
from the bronchial lumen via the afferent lymphatics or via
the bloodstream, causing local damage to resident LN DCs.
In support of the latter, we observed partial depletion of sys-
temic DCs; however, not to the degree seen in the airways.
Using this unique system, we conditionally depleted
CD11c  cells locally from the lung immediately before
OVA challenge in OVA-sensitized mice and saw that the
Figure 6. Adoptive transfer of DCs is sufficient to induce all 
asthmatic features in sensitized mice. Mice were OVA DC sensitized at 
day 0, received at days 10 and 12 an i.t. injection of OVA DCs (black bars), 
or received at days 10–13 a daily OVA aerosol (white bars) or PBS aerosols 
(diagonally striped bars). (A and B) At day 14, total BALF cells numbers and 
eosinophil numbers were determined by FACS (*, P   0.05 vs. DC/PBS). 
(C) Th2 cytokine production by MLNs was determined after ex vivo restim-
ulation with OVA. IL-4, IL-5, IL-13, and IFN-  were measured in supernatant 
by ELISA. (D–F) Histological lung sections of mice challenged with OVA 
DCs (DC/DC), OVA aerosols (DC/OVA), and PBS aerosols (DC/PBS). (G) Airway 
responsiveness was increased in DC/DC and DC/OVA compared with DC/PBS 
mice. The results represent one out of two independent experiments and 
are expressed as means   SEM.DENDRITIC CELLS IN ASTHMA | van Rijt et al. 988
cardinal features of asthma such as eosinophilic airway in-
flammation, goblet cell hyperplasia, and bronchial hyperre-
activity to metacholine failed to develop. As these features
critically depend on CD4  T cells and their secreted prod-
ucts, the most likely explanation was that effector function
was not induced in the absence of CD11c  cells. In support
of this theory, we saw that in the absence of CD11c  cells,
ex vivo–isolated CD4  cells produced greatly diminished
amounts of IL-4, IL-5, and IL-13. We adoptively transferred
in vitro–primed CD4  Th2 cells from DO11.10 TCR Tg T
cells in CD11c cell–depleted mice. Previous data have
shown that such in vitro–differentiated Th2 cells mimic in
vivo–generated memory T cells (31, 32) and can be used to
transfer Th2 reactivity to OVA aerosol passively (24). How-
ever, when Th2 cells were adoptively transferred in mice
that were depleted of CD11c  cells, no Th2 effector cyto-
kines IL-4, IL-5, and IL-13 were produced by the T cells in
the draining LNs of the lung, whereas they readily did in the
presence of lung CD11c  DCs. Together, these data show
that CD11c  cells are necessary for mounting the secondary
response to OVA challenge in previously sensitized mice
through the induction of effector function in primed Th2
cells. In view of the unique antigen-presenting characteris-
tics of DCs in the airways, it is very likely that these effects
were due to depletion of CD11c  DCs and not CD11c  au-
tofluorescent alveolar macrophages because of several rea-
sons. First, as direct proof, all the salient features of asthma
were restored by i.t. adoptive transfer of wild-type bone
marrow–derived CD11c  myeloid DCs, but not by transfer
of CD11c  wild-type alveolar macrophages. Second, studies
by Huh et al. and our own studies show a predominant in-
teraction between CD4  T cells and DCs in the submucosa
of the airways, at distant sites from alveolar macrophages,
making a functional contribution of these cells less likely
(10). Third, previous studies in mice in which alveolar mac-
rophages were depleted using clodronate-filled liposomes
have seen an actual enhancement of airway inflammation
and T cell reactivity in the lung (33). This is explained by
the normally suppressive influence of alveolar macrophages
on activation of primed T cells and DCs in the lung (3). The
fact that airway inflammation was severely suppressed in the
combined absence of CD11c  DCs and CD11c  alveolar
macrophages attests to the crucial role that CD11c  DCs
play during the secondary response.
As the CD11c marker is also expressed weakly on acti-
vated CD8  T cells (34), we performed adoptive transfer re-
constitution experiments of wild-type CD8  T cells to DT-
treated mice, again failing to restore the eosinophilic airway
inflammation and Th2 cytokine production. Moreover,
CD8-deficient (35) and  2-microglobulin–deficient mice
(36) develop normal airway eosinophilia in mouse models of
asthma. Eosinophils express very low levels of CD11c (37)
and, thus, are likely to be less sensitive to DT compared with
DCs. We cannot completely exclude that DT would target
eosinophils directly. However, treatment with DT reduced
not only eosinophilia but also effector Th2 cytokine secre-
tion, goblet cell hyperplasia, and bronchial hyperreactivity,
strongly suggesting that the main effect of DT treatment was
on CD11c  DCs, leading to a failure of T cell activation. In
support of this, i.t. reconstitution with wild-type eosinophils
did not restore eosinophilia in the BAL compartment nor
the secretion of effector Th2 cytokines.
These data of local depletion of CD11c  DCs immedi-
ately before antigen challenge to the lung support our previ-
ous work in which we systemically depleted all myeloid DCs
from the lungs, LNs, bone marrow, and spleen of HIV-LTR
promoter-driven thymidine kinase Tg mice before allergen
challenge. In thymidine kinase Tg mice, conditional deple-
tion of DCs took considerably more time as it depended on
killing of dividing DC precursors and had to be performed
before T cell activation as the HIV-LTR promoter used to
drive transgene expression was also activated in effector T
cells, a problem not encountered in the CD11c DTR Tg
mice. Therefore, next we questioned what would be the
role of lung DCs during ongoing inflammation at a time
when fully activated effector CD4  Th2 cells are already
causing all the features of asthma. When CD11c  DCs were
depleted in the middle of the OVA aerosol period, all the sa-
lient features of asthma were strongly diminished, and effec-
tor cytokine secretion was strongly reduced. We observed
that eosinophilia actually resolved despite ongoing allergen
exposure when DCs were depleted from the airways, and
the speed of resolution was similar to mice no longer ex-
posed to allergen.
Although these depletion studies show that DCs are re-
quired for eosinophilic airway inflammation in vivo, we
looked for additional proof to show that they are also suffi-
cient to induce all asthma features. Repeated i.t. injection of
OVA-pulsed DCs in the absence of any adjuvant or aerosol,
commonly used in all other asthma models, induced all the
cardinal features of asthma, including Th2 cytokine activa-
tion and bronchial hyperreactivity. As this response did not
occur in SCID mice devoid of lymphocytes, it seems that
DCs mediate their effect by first sensitizing naive T cells to
become Th2 cells, and subsequently restimulate these cells to
cause disease, although it is not completely excluded that
DCs also have direct effector activities.
Based on studies on the functional interaction between
mucosal T cells and DCs (10) and based on our current find-
ings, it is clear that effector Th2 responses in vivo in the lung
continuously depend on antigen-presenting DCs. One pos-
sible explanation would be that effector T cells in vivo re-
main dependent on costimulation in contrast with their in
vitro counterparts (20, 38). Numerous models of asthma
have demonstrated that blocking the interaction of costim-
ulatory molecules of the B7 superfamily (CD80, CD86,
ICOS-L) or TNF-R family (OX40L) can reduce the features
of asthma, even when given during challenge in sensitized
mice and even when given together with in vitro–primed
Th2 cells (39–43). As lung DCs are the predominant cellJEM VOL. 201, March 21, 2005 989
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type expressing these molecules (Fig. 1 A), an absence of
DCs might have the same effect as blocking these costimula-
tory molecules. An alternative explanation would be that
lung DCs are essential for the recruitment of Th2 cells by
producing Th2 selective chemokines. Indeed, it was shown
that lung CD11c  DCs within sites of eosinophilic airway
inflammation and human monocyte-derived DCs exposed
to the house dust mite allergen Der p 1 produce high
amounts of the Th2-selective chemokine TARC, acting on
CCR4  Th2 cells (18, 44). Therefore, depletion of lung
DCs might lead to an “unfavorable” chemokine gradient,
failing to attract primed Th2 cells to the lung.
Our findings that DCs are essential for mounting second-
ary T lymphocyte effector responses might prove to be im-
portant for explaining other T cell–mediated diseases such as
diabetes, multiple sclerosis, rheumatoid arthritis, and colitis. It
was shown recently that mature OX40L  DCs form exten-
sive clusters with pathogenic T cells in the gut mucosa in the
CD45RBhi transfer model of colitis in SCID mice (45). Sim-
ilarly, in T cell–mediated peri-insulitis of prediabetic NOD
mice, DCs are prominently present and cluster with patho-
genic T cells (46). Although formally not yet proven, it is
very likely that in light of our data, DCs are essential for acti-
vation of pathogenic T cells in these diseases as well.
In conclusion, our findings identify lung DCs as key
proinflammatory cells that are necessary and sufficient for
Th2 cell stimulation during ongoing airway inflammation
and validate the airway DC as a novel target for directed
therapy of asthma.
MATERIALS AND METHODS
Animals
Wild-type BALB/c and CD11c-DTR Tg BALB/c mice were housed under
specific pathogen-free conditions at the animal facility of Erasmus MC and
experiments were approved by the animal ethical committee. The generation
and screening of CD11c-DTR Tg mice has been reported previously (23).
Culture and antigen pulsing of bone marrow DCs
Bone marrow cells were collected from naive mice, depleted of red blood
cells using ammonium chloride, and grown in RPMI 1640 culture medium
containing 5% FCS (Sigma-Aldrich) and rmGM-CSF (provided by K.
Thielemans, Free University, Brussels, Belgium) for 9 d as described previ-
ously (47). At day 9, they were pulsed in vitro overnight with 100  g/ml
OVA (Worthington Biochemical Corp.; LPS contamination  29 EU/mg
LPS by LAL assay) (OVA-DC) or sham-pulsed with PBS (PBS-DC).
Asthma model using OVA-pulsed DC immunization followed by 
OVA aerosol challenge
To induce sensitization to inhaled OVA, 106 BM-derived OVA-DCs were
injected intratracheally into the airways of naive anesthetized mice, as de-
scribed previously (8). 10 d after i.t. immunization, mice were challenged
with OVA aerosol (1% wt/vol in PBS; Sigma-Aldrich; using a jet nebulizer)
during a daily 30-min challenge on three to six consecutive days, generating
vigorous eosinophilic airway inflammation (8). Experiments using Ly5.1 
DC adoptive transfer into Ly5.2 recipients demonstrated that none of the
transferred DCs remained in the lungs at the time of allergen challenge (un-
published data). To address their functional role in generating airway in-
flammation, endogenous CD11c  DCs were depleted before or during
OVA challenge.
In a first series of experiments, CD11c-DTR Tg mice and nTg litter-
mates were sensitized to OVA at day 0. At day 10, all mice received an i.t
injection of 50 ng DT to deplete CD11c  cells and were subsequently chal-
lenged with three daily OVA or control PBS aerosols from days 11–13.
Mice were killed at day 14.
In another series of experiments to address the role of DCs in already
established inflammation, CD11c-DTR Tg mice and nTg littermates were
sensitized to OVA at day 0 and subsequently challenged with three OVA
aerosols on days 10–12. On day 13, all mice received an i.t. injection of 50
ng DT. On days 14–16, mice were further aerosolized with OVA or as a
control with PBS. Mice were killed at day 17.
Adoptive transfer reconstitution experiments were performed in DT-
treated CD11c DTR Tg mice with the following wild-type cells: unpulsed
bone marrow–derived DCs; alveolar macrophages (98% pure from pooled
BALF of naive mice); eosinophils (89% pure sorted based on CCR3 expres-
sion from pooled BALF of allergic mice as described previously [37]); and
CD8  cells (purified to 85% using negative depletion beads [Miltenyi Bio-
tec] from the spleen and LNs of OVA-sensitized and -challenged mice). 
Asthma model using only adoptive transfer of DCs
In separate experiments, OVA aerosol challenge was compared with chal-
lenge with OVA-pulsed DCs in OVA-DC– or PBS-DC–sensitized mice.
Mice received two i.t. injections of 106 OVA-DCs at day 10 and day 12.
Alternatively, mice were aerosolized with OVA at days 10–13. Animals
were killed 24 h after the last aerosol or 48 h after the last DC injection.
Adoptive transfer of OVA-specific Th2 cells
In some experiments, naive mice received adoptive transfer of in vitro–dif-
ferentiated Th2 cells obtained from DO11.10 OVA-TCR Tg mice.
DO11.10 LN cells were stimulated with OVA for 6 d in the presence of 10
ng/ml IL-4, 10  g/ml anti-IFN , 1  g/ml anti–IL-12, and 5  g/ml OVA
peptide. Th2 differentiation was confirmed by quantitative PCR trough a
360-fold increase in mRNA for IL-4, 892-fold increase in IL-5, and 608-
fold increase in IL-13, whereas mRNA for IFN  was unaffected compared
with naive DO11.10 T cells. After 6 d, cells were washed, and 3   106 cells
were injected i.v. into naive CD11c-DTR Tg mice treated simultaneously
or not with DT to deplete DCs. Mice were challenged with daily OVA
aerosols for the subsequent 4 d. Th2 cytokine production by lung draining
LNs was determined ex vivo 24 h after the last aerosol challenge.
Collection and analysis of cells and tissues
BALF.  24 h after the last aerosol, BAL was performed with 3  1 ml of
Ca2 - and Mg2 -free PBS. After red blood cell lysis using ammonium chlo-
ride lysis buffer, cells were stained with MHCII-FITC (2G9), CD11c-APC
(HL3), B220-CyChr (RA3-6B2), CD3-CyChr (145-2C11; BD Bio-
sciences), and CCR3-PE (R&D Systems). 2.4.G2 was used to prevent non-
specific binding. The cellular composition of BALF cells was determined
using flow cytometry as described previously (37) on a FACScalibur flow
cytometer using CELLQuest (Becton Dickinson) and FlowJo software
(Treestar).
LNs. LN cell suspensions were plated in 96-well round bottom plates at a
density of 2   105 cells per well and were restimulated for 4 d with 10  g/
ml OVA. After 4 d, levels of IL-4, IL-5, IFN-  (OptEIA; BD Biosciences
and Becton Dickinson) and IL-13 (R&D Systems) were measured by
ELISA. Numbers of CD11c  MHCII  DCs were measured using flow cy-
tometry in homogenized lung draining LNs at 48 h after DT injection. LNs
were homogenized after collagenase and DNase I treatment as described
previously (7).
Airway histology.  Frozen sections were stained with hematoxylin eosin
or with Periodic Acid Schiff’s reagent (Sigma-Aldrich). For immunohis-
tochemical identification of CD11c  DCs and CD4  T cells, lung sections
were fixed in acetone, and endogenic peroxidase was blocked with 0.1%DENDRITIC CELLS IN ASTHMA | van Rijt et al. 990
SoAz/0.01% H2O2 in PBS for 30 min, blocked with NGS and NRS, and
incubated with hamster anti-CD11c followed by goat anti–Armenian ham-
ster PO (Jackson ImmunoResearch Laboratories); to stain for CD4, sections
were incubated with rat anti–mouse CD4-FITC (BD Biosciences), fol-
lowed by rabbit anti-FITC–AP (DakoCytomation and ITK). Signal was de-
veloped with AEC and Fast blue, respectively.
Measurement of AHR using whole-body plethysmography
Airway responsiveness to inhaled metacholine was measured by barometric
plethysmography in conscious mice (EMKA Technologies) as described
previously (48). 24 h after the last aerosol challenge, nonspecific responsive-
ness was measured by exposing mice to aerosolized PBS to set a baseline
value, followed by increasing concentrations of aerosolized metacholine
(1.5625, 3.125, 6.25, 12.5, and 25 mg/ml in PBS for 3 min; Sigma-Aldrich)
using ultrasonic nebulizers. PenH (enhanced pause) values were measured
during 3 min after each metacholine aerosol. The average PenH values
were expressed for each MCH concentration as the percentage increase
over baseline PenH values measured after PBS exposure.
Statistical analysis
All experiments were performed using 5–10 mice per group. Comparison of
means between different groups was performed with a Kruskal-Wallis test
for equality and, in case of a significant difference the Mann-Whitney U test
for unpaired data, was used for comparing two groups (SPSS 11.0 for Win-
dows) separately. Differences were considered significant if P   0.05. To
compare histology sections, we ordered sections based on presence of goblet
cell hyperplasia, perivascular and peribronchial eosinophilic infiltrates, and
parenchymal inflammatory cells. By assigning each section a number, start-
ing with the least inflamed section assigning 1, the scores per group were
compared with a Kruskal-Wallis test and, in case of significance, with a
Mann-Whitney U test. Degree of inflammatory infiltrates around airways
was quantified by measuring the area of inflammatory infiltrate using an im-
age analyzing system. The inflammatory surfaces were corrected for the size
of the airway by the following formula: (area inflammatory infiltrate   area
airways)/area airways. These values were also compared with a Kruskal-
Wallis test and, in case of significance, with a Mann-Whitney U test.
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